These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7594803

  • 1. Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours.
    Bornstein BA, Herman TS, Hansen JL, Buswell L, Zouranjian PS, Fraser SM, Teicher BA, Svensson GK, Coleman CN.
    Int J Hyperthermia; 1995; 11(4):489-99. PubMed ID: 7594803
    [Abstract] [Full Text] [Related]

  • 2. Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma.
    Bornstein BA, Zouranjian PS, Hansen JL, Fraser SM, Gelwan LA, Teicher BA, Svensson GK.
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):79-85. PubMed ID: 7677990
    [Abstract] [Full Text] [Related]

  • 3. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC, Palmer M, Kinney B, Belch A, Hewitt J, Hanson J.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):337-42. PubMed ID: 9457818
    [Abstract] [Full Text] [Related]

  • 4. Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and outcome.
    Buswell L, Recht A, Clark J, Ravikumar T, Busse PM, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):535-40. PubMed ID: 8005812
    [Abstract] [Full Text] [Related]

  • 5. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA, Pfeffer MR, Alvarez Sotomayor E, Herman TS.
    Int J Hyperthermia; 1991 Jun 15; 7(5):773-84. PubMed ID: 1834752
    [Abstract] [Full Text] [Related]

  • 6. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies.
    Herman TS, Jochelson MS, Teicher BA, Scott PJ, Hansen J, Clark JR, Pfeffer MR, Gelwan LE, Molnar-Griffin BJ, Fraser SM.
    Int J Radiat Oncol Biol Phys; 1989 Dec 15; 17(6):1273-9. PubMed ID: 2689396
    [Abstract] [Full Text] [Related]

  • 7. Summary of studies adding systemic chemotherapy to local hyperthermia and radiation.
    Herman TS, Teicher BA.
    Int J Hyperthermia; 1994 Dec 15; 10(3):443-9. PubMed ID: 7930812
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial.
    Riese NE, Buswell L, Noll L, Pajak TF, Stetz J, Lee DJ, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1997 Nov 01; 39(4):855-8. PubMed ID: 9369134
    [Abstract] [Full Text] [Related]

  • 9. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1182-5. PubMed ID: 12654425
    [Abstract] [Full Text] [Related]

  • 10. Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03.
    Coleman CN, Wasserman TH, Urtasun RC, Halsey J, Noll L, Hancock S, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1990 Feb 01; 18(2):389-93. PubMed ID: 2154420
    [Abstract] [Full Text] [Related]

  • 11. Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group study.
    Coleman CN, Noll L, Riese N, Buswell L, Howes AE, Loeffler JS, Alexander E, Wen P, Harris JR, Kramer RA.
    Int J Radiat Oncol Biol Phys; 1992 Feb 01; 22(3):577-80. PubMed ID: 1531217
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area.
    van Meerten E, Franckena M, Wiemer E, van Doorn L, Kraan J, Westermann A, Sleijfer S.
    Oncologist; 2015 Mar 01; 20(3):241-2. PubMed ID: 25660155
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB.
    Chest; 1999 Jan 01; 115(1):144-50. PubMed ID: 9925076
    [Abstract] [Full Text] [Related]

  • 18. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE, Haraf DJ, Drinkard LC, Hoffman PC, Ferguson MK, Vogelzang NJ, Watson S, Lane NJ, Golomb HM.
    Cancer Chemother Pharmacol; 1995 Jan 01; 35(4):304-12. PubMed ID: 7530173
    [Abstract] [Full Text] [Related]

  • 19. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL.
    Anticancer Res; 1999 Jan 01; 19(5C):4463-7. PubMed ID: 10650793
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer.
    Chen MD, Paley PJ, Potish RA, Twiggs LB.
    Gynecol Oncol; 1997 Nov 01; 67(2):131-6. PubMed ID: 9367695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.